Plaque Psoriasis Comparator Study (68 Weeks)

Adults 18 years of age or older with a diagnosis of chronic plaque psoriasis for at least 6 months, may qualify to participate in this study.  Eligible participants must have plaque psoriasis involving 10% or more of their body, with moderate to severe disease at the time of study entry.

Participants will receive investigational medication (active drug), active comparator or placebo via subcutaneous injection.  Reimbursement for study-related expenses will be provided.

Study participation will last up to 68 weeks and include 18 visits to the study centre.

Call the study centre near you, or register now.

Learn more about
Psoriasis
Register Now!

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more